With a more fragmented market, increased product launches and the need to prove value to stakeholders, the demands of precision medicine will strain the capabilities of pharmaceutical marketing and commercial operations. To survive, pharmaceutical organizations will need to reengineer processes, tap into new data sources and adopt sophisticated analytics to help them launch more products with smaller target markets.
With our breadth of experience and relationships with healthcare and life science organizations, we can help. We offer a full complement of business consulting and system integration that can help you succeed at value-based contracting and data-driven, patient-centered marketing strategies. We can help you integrate a wide array of data sources, gain valuable insights from the data, and create new processes and systems to meet the needs of precision medicine.
After looking at our comprehensive portfolio of ITO capabilities for the
life sciences industry, IDC named us a Leader in Worldwide Life Science
R&D ITO Services in its latest Marketscape vendor assessment. Their
assessment cites strong project leadership, high quality of work
and a sharing of best practices with our clients.